Cryoport, Inc. (CYRX)
NASDAQ: CYRX · Real-Time Price · USD
6.23
-0.81 (-11.51%)
Mar 13, 2025, 12:57 PM EDT - Market open
Cryoport Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 228.39 | 233.26 | 237.28 | 222.61 | 78.7 | Upgrade
|
| Revenue Growth (YoY) | -2.09% | -1.70% | 6.59% | 182.87% | 131.85% | Upgrade
|
| Cost of Revenue | 128.75 | 133.92 | 133.4 | 126.03 | 42.36 | Upgrade
|
| Gross Profit | 99.63 | 99.33 | 103.87 | 96.58 | 36.33 | Upgrade
|
| Selling, General & Admin | 148.04 | 140.54 | 120.06 | 97.56 | 46.66 | Upgrade
|
| Research & Development | 17.71 | 18.04 | 15.72 | 16.84 | 9.48 | Upgrade
|
| Operating Expenses | 165.75 | 158.58 | 135.78 | 114.41 | 56.14 | Upgrade
|
| Operating Income | -66.12 | -59.24 | -31.9 | -17.83 | -19.81 | Upgrade
|
| Interest Expense | -4.11 | -5.5 | -6.14 | -4.69 | -2.56 | Upgrade
|
| Interest & Investment Income | 9.9 | 10.58 | 8.47 | 3.25 | 0.76 | Upgrade
|
| Currency Exchange Gain (Loss) | -1 | -1.9 | -3.8 | -10.7 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.87 | 5.71 | -4.36 | 7.88 | -0.68 | Upgrade
|
| EBT Excluding Unusual Items | -62.2 | -50.36 | -37.74 | -22.09 | -22.29 | Upgrade
|
| Merger & Restructuring Charges | -2.78 | -6.95 | - | - | -10.2 | Upgrade
|
| Impairment of Goodwill | -54.56 | -49.57 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.04 | 1.24 | - | - | -0.25 | Upgrade
|
| Asset Writedown | -9.25 | - | - | - | - | Upgrade
|
| Other Unusual Items | 20.35 | 6.28 | - | -251.75 | - | Upgrade
|
| Pretax Income | -113.48 | -99.35 | -35.09 | -273.84 | -32.74 | Upgrade
|
| Income Tax Expense | 1.28 | 0.24 | 2.24 | 1.69 | -0.05 | Upgrade
|
| Net Income | -114.76 | -99.59 | -37.33 | -275.53 | -32.69 | Upgrade
|
| Preferred Dividends & Other Adjustments | 8 | 8 | 8 | 8.2 | 42.34 | Upgrade
|
| Net Income to Common | -122.76 | -107.59 | -45.33 | -283.72 | -75.03 | Upgrade
|
| Shares Outstanding (Basic) | 49 | 49 | 49 | 46 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 49 | 49 | 49 | 46 | 39 | Upgrade
|
| Shares Change (YoY) | 1.26% | -0.51% | 6.66% | 19.04% | 15.54% | Upgrade
|
| EPS (Basic) | -2.49 | -2.21 | -0.93 | -6.18 | -1.94 | Upgrade
|
| EPS (Diluted) | -2.49 | -2.21 | -0.93 | -6.18 | -1.94 | Upgrade
|
| Free Cash Flow | -33.58 | -39.54 | -23.96 | -15.76 | -23.78 | Upgrade
|
| Free Cash Flow Per Share | -0.68 | -0.81 | -0.49 | -0.34 | -0.62 | Upgrade
|
| Gross Margin | 43.62% | 42.59% | 43.78% | 43.38% | 46.17% | Upgrade
|
| Operating Margin | -28.95% | -25.40% | -13.45% | -8.01% | -25.17% | Upgrade
|
| Profit Margin | -53.75% | -46.12% | -19.11% | -127.45% | -95.34% | Upgrade
|
| Free Cash Flow Margin | -14.70% | -16.95% | -10.10% | -7.08% | -30.22% | Upgrade
|
| EBITDA | -35.36 | -31.76 | -9.14 | 2.42 | -9.94 | Upgrade
|
| EBITDA Margin | -15.48% | -13.61% | -3.85% | 1.09% | -12.63% | Upgrade
|
| D&A For EBITDA | 30.76 | 27.49 | 22.77 | 20.25 | 9.87 | Upgrade
|
| EBIT | -66.12 | -59.24 | -31.9 | -17.83 | -19.81 | Upgrade
|
| EBIT Margin | -28.95% | -25.40% | -13.45% | -8.01% | -25.17% | Upgrade
|
| Revenue as Reported | 228.39 | 233.26 | 237.28 | 222.61 | 78.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.